Dr. Reddy's Laboratories (RDY) shares outstanding
Dr. Reddy's Laboratories (RDY) had 833.33M diluted shares on average in fiscal 2026 (the year ended March 31, 2026). That is 0.1% lower than the 834.21M of fiscal 2025. Figures as of 18 Nov 2026, 12:42 UTC, from Yahoo Finance.
Key facts
- Shares outstanding, fiscal 2026
- 833.33M
- Change on fiscal 2025
- −0.1%
- Highest on record
- 834.21Mfiscal 2025
- Lowest on record
- 831.91Mfiscal 2023
- Fiscal years on record
- 42023–2026
Figures as of . Statements from Yahoo Finance. Figures, not advice.
Dr. Reddy's Laboratories shares outstanding, in more detail
The market data feed counts 833.66M shares outstanding today.
Across the 4 fiscal years on record (2023–2026), the highest was 834.21M in fiscal 2025 and the lowest 831.91M in fiscal 2023.
Shares outstanding by fiscal year
Dr. Reddy's Laboratories shares outstanding, year by year
| Fiscal year | Shares outstanding | Change | Year ended |
|---|---|---|---|
| 2026 | 833.33M | 0.1% down | |
| 2025 | 834.21M | 0.1% up | |
| 2024 | 833.54M | 0.2% up | |
| 2023 | 831.91M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.
How to read it
A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.
Shares outstanding at health care companies of similar size
| Company | Shares outstanding | Fiscal year |
|---|---|---|
| Smith & Nephew SNN | 436.45M | 2025 |
| Penumbra PEN | 39.29M | 2025 |
| Dr. Reddy's Laboratories RDY | 833.33M | 2026 |
| Align Technology ALGN | 72.59M | 2025 |
| Cooper Companies COO | 200.00M | 2025 |
| Fresenius Medical Care FMS | 582.38M | 2025 |
The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.
Dr. Reddy's Laboratories, figure by figure
- Dr. Reddy's Laboratories market cap
- Dr. Reddy's Laboratories revenue
- Dr. Reddy's Laboratories earnings
- Dr. Reddy's Laboratories earnings per share (EPS)
- Dr. Reddy's Laboratories P/E ratio
- Dr. Reddy's Laboratories P/S ratio
- Dr. Reddy's Laboratories P/B ratio
- Dr. Reddy's Laboratories free cash flow
- Dr. Reddy's Laboratories operating margin
- Dr. Reddy's Laboratories dividend
- Dr. Reddy's Laboratories total debt
- Dr. Reddy's Laboratories cash on hand
- Dr. Reddy's Laboratories total assets
- Dr. Reddy's Laboratories return on equity (ROE)
- Dr. Reddy's Laboratories return on invested capital (ROIC)
Dr. Reddy's Laboratories (RDY) overview: price, valuation and scorecardAll health care companies by market value
Dr. Reddy's Laboratories shares outstanding: questions and answers
How many shares does Dr. Reddy's Laboratories have?
Dr. Reddy's Laboratories (RDY) had 833.33M diluted shares on average in fiscal 2026 (the year ended March 31, 2026). That is 0.1% lower than the 834.21M of fiscal 2025. The market data feed counts 833.66M shares outstanding today.
What are the highest and lowest diluted share count figures on record for Dr. Reddy's Laboratories?
Across the 4 fiscal years on record (2023–2026), the highest was 834.21M in fiscal 2025 and the lowest 831.91M in fiscal 2023.
How is Dr. Reddy's Laboratories's diluted share count calculated?
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Dr. Reddy's Laboratories it is on record here for 4 fiscal years, 2023 to 2026.
Fiscal years are named for the calendar year they end in.
Learn: shares outstanding
All stocks guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Dr. Reddy's Laboratories (RDY) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/RDY/shares-outstanding
Underlying data: Yahoo Finance.